Pages that link to "Q42580467"

The following pages link to Upregulation of NRG-1 and VAMP-1 in human brain aggregates exposed to clozapine (Q42580467):

Displaying 14 items.

• Regulation of intracellular membrane trafficking and cell dynamics by syntaxin-6 (Q24633280) (← links)
• Neuregulin-1 signalling and antipsychotic treatment: potential therapeutic targets in a schizophrenia candidate signalling pathway (Q28285114) (← links)
• The endogenous and reactive depression subtypes revisited: integrative animal and human studies implicate multiple distinct molecular mechanisms underlying major depressive disorder (Q33715064) (← links)
• A novel mechanism and treatment target for presynaptic abnormalities in specific striatal regions in schizophrenia (Q34660862) (← links)
• Transcriptome sequencing revealed significant alteration of cortical promoter usage and splicing in schizophrenia. (Q35918319) (← links)
• Biomarker investigations related to pathophysiological pathways in schizophrenia and psychosis. (Q36955877) (← links)
• Suberoylanilide hydroxamic acid induces limited changes in the transcriptome of primary CD4( ) T cells. (Q37119662) (← links)
• Genomics and pharmacogenomics of schizophrenia (Q37780792) (← links)
• Pharmacogenomics of antipsychotics efficacy for schizophrenia (Q37832287) (← links)
• A systematic review of antipsychotic drug effects on human gene expression related to risk factors for cardiovascular disease (Q38194900) (← links)
• BACE1-Dependent Neuregulin-1 Signaling: An Implication for Schizophrenia (Q42004797) (← links)
• HIV downregulates interferon-stimulated genes in primary macrophages (Q42573471) (← links)
• Elevated peripheral expression of neuregulin-1 (NRG1) mRNA isoforms in clozapine-treated schizophrenia patients (Q46270751) (← links)
• Future Trends in the Pharmacogenomics of Brain Disorders and Dementia: Influence of APOE and CYP2D6 Variants. (Q55266735) (← links)